✦ LIBER ✦

Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy

✍ Scribed by Waters, David D.; Ho, Jennifer E.; Boekholdt, S. Matthijs; DeMicco, David A.; Kastelein, John J.P.; Messig, Michael; Breazna, Andrei; Pedersen, Terje R.

Book ID: 120188282
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 444 KB
Volume: 61
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2012.09.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of New-Onset Diabetes Mellitus Vers

Risk of New-Onset Diabetes Mellitus Versus Reduction in Cardiovascular Events With Statin Therapy

✍ Wang, Kang-Ling; Liu, Chia-Jen; Chao, Tze-Fan; Chen, Su-Jung; Wu, Cheng-Hsueh; H 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 780 KB

RISK OF NEW-ONSET DIABETES AND CARDIOVAS

RISK OF NEW-ONSET DIABETES AND CARDIOVASCULAR RISK REDUCTION FROM STATIN THERAPY DIFFERS IN PRE-DIABETICS AND NON PRE-DIABETICS: A TNT AND IDEAL SUBSTUDY

✍ Kohli, Payal; Waters, David; Arsenault, Benoit; Messig, Michael; Laskey, Rachel; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 179 KB